Key Takeaways
Hyperion DeFi, Inc. (NASDAQ: HYPD) rose 2.04 percent after reporting a record $8.84 million in net income for the first quarter of 2026 and raising its full-year profit guidance by 20 percent, signaling that its on-chain operating strategy on the Hyperliquid blockchain is scaling.
"We are pleased to report continued scaling of our DeFi operating businesses, accretive balance sheet growth, and prudent cost management," Hyunsu Jung, CEO of Hyperion DeFi, said in a statement. "The opportunities to build on Hyperliquid are immense and expanding every day. We continue to position ourselves as the premier institutional gateway to DeFi innovation."
The company's record net income marks a significant turnaround from a net loss of $39.77 million in the fourth quarter of 2025. Hyperion also posted Q1 Adjusted EBITDA of $19.5 million and increased its 2026 Adjusted Gross Profit guidance to a range of $5 million to $7 million, up from a prior estimate of $4 million to $6 million. Growth was driven by a 140 percent quarterly increase in DeFi Monetization and a 165 percent increase in Yield Enhancement activities.
While the firm's operating businesses show strong growth, the results also highlight its exposure to the volatility of the HYPE token and its reliance on capital raising. The company used $4.2 million in cash for operating activities and raised capital through an at-the-market offering and a public offering of 2.78 million shares, which creates dilution for existing shareholders. The results reinforce a narrative of strong operational growth paired with digital-asset risk.
Hyperion DeFi, the first U.S. publicly listed DeFi company building on the Hyperliquid layer-one blockchain, explained that its unique "Triple-Dip" strategy generated approximately 3.1 times the income it would have from base staking alone. This strategy involves staking HYPE, deploying the staked assets into other business lines like its validator or yield strategies, and positioning the company for ecosystem rewards from partners like Kinetiq and HyperLend.
As of May 11, the company's treasury held over 2.00 million HYPE tokens, with Gross HYPE Holdings valued at $84.5 million. Cash, cash equivalents, and USDH stablecoins totaled approximately $16.0 million. The growth in its treasury and operating businesses comes as the company expects to wind down its legacy biotech operations by the end of the second quarter of 2026, which is anticipated to lower quarterly operating expenses below $3.0 million.
This article is for informational purposes only and does not constitute investment advice.
